Distribution of MC1R variants among melanoma subtypes: P.R163Q is associated with lentigo maligna melanoma in a Mediterranean population

British Journal of Dermatology

Volumn 169, Issue 4, 2013, Pages 804-811

  Puig Butille J A ^a,b   Carrera, C ^a,b   Kumar, R ^c   Garcia Casado, Z ^d   Badenas, C ^a,b   Aguilera, P ^a   Malvehy, J ^a   Nagore, E ^d   Puig, S ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOMINANT INHERITANCE; EYE COLOR; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAIR COLOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT LENTIGO; MC1R GENE; MELANOMA; PIGMENTATION; PRIORITY JOURNAL; SKIN COLOR; SOUTHERN EUROPE;

EYE COLOR; GENETIC VARIATION; HAIR COLOR; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MEDITERRANEAN REGION; MELANOMA; NUCLEOTIDES; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 1; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 84885587653     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12418     Document Type: Article

References (49)

1. Marks R,. Epidemiology of melanoma. Clin Exp Dermatol 2000; 25: 459-63.
2. Clark WH Jr, From L, Bernardino EA, Mihm MC,. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-27.
3. Elwood JM, Hislop TG,. Solar radiation in the etiology of cutaneous malignant melanoma in Caucasians. Natl Cancer Inst Monogr 1982; 62: 167-71.
4. Holman CD, Armstrong BK,. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 75-82.
5. Forman SB, Ferringer TC, Peckham SJ, et al,. Is superficial spreading melanoma still the most common form of malignant melanoma? J Am Acad Dermatol 2008; 58: 1013-20.
6. Shaikh WR, Xiong M, Weinstock MA,. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol 2011; 148: 30-6.
7. Rodenas JM, Delgado-Rodriguez M, Herranz MT, et al,. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 1996; 7: 275-83.
8. Ballester I, Oliver V, Bañuls J, et al,. Multicenter case-control study of risk factors for cutaneous melanoma in Valencia, Spain. Actas Dermosifiliogr 2012; 103: 790-7.
9. Tucker MA, Goldstein AM,. Melanoma etiology: where are we? Oncogene 2003; 22: 3042-52.
10. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
11. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040-59.
12. Rees JL,. Genetics of hair and skin color. Annu Rev Genet 2003; 37: 67-90.
13. García-Borrón JC, Sánchez-Laorden BL, Jiménez-Cervantes C,. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 2005; 18: 393-410.
14. Raimondi S, Sera F, Gandini S, et al,. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008; 122: 2753-60.
15. Gerstenblith MR, Goldstein AM, Fargnoli MC, et al,. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007; 28: 495-505.
16. Landi MT, Bauer J, Pfeiffer RM, et al,. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006; 313: 521-2.
17. Fargnoli MC, Pike K, Pfeiffer RM, et al,. MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol 2008; 128: 2485-90.
18. Hacker E, Hayward NK, Dumenil T, et al,. The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. J Invest Dermatol 2010; 130: 241-8.
19. Thomas NE, Kanetsky PA, Edmiston SN, et al,. Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study. J Invest Dermatol 2010; 130: 1463-5.
20. Scherer D, Rachakonda PS, Angelini S, et al,. Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors. J Invest Dermatol 2010; 130: 2844-8.
21. Fitzpatrick TB,. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
22. Chaudru V, Laud K, Avril MF, et al,. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev 2005; 14: 2384-90.
23. Scherer D, Nagore E, Bermejo JL, et al,. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 2009; 125: 1868-75.
24. Adzhubei IA, Schmidt S, Peshkin L, et al,. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-9.
25. Solé X, Guinó E, Valls J, et al,. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22: 1928-9.
26. Arrington JH 3rd, Reed RJ, Ichinose H, Krementz ET,. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1: 131-43.
27. Clark WH Jr, Mihm MC Jr,. Lentigo maligna and lentigo-maligna melanoma. Am J Pathol 1969; 55: 39-67.
28. Clark WH Jr, Elder DE, Van Horn M,. The biologic forms of malignant melanoma. Hum Pathol 1986; 17: 443-50.
29. Porras BH, Cockerell CJ,. Cutaneous malignant melanoma: classification and clinical diagnosis. Semin Cutan Med Surg 1997; 16: 88-96.
30. Berwick M, Wiggins C,. The current epidemiology of cutaneous malignant melanoma. Front Biosci 2006; 11: 1244-54.
31. Valverde P, Healy E, Jackson I, et al,. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995; 11: 328-30.
32. Healy E, Flannagan N, Ray A, et al,. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 2000; 355: 1072-3.
33. Orlow I, Tommasi DV, Bloom B, et al,. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. J Invest Dermatol 2009; 129: 1972-82.
34. Murali R, Goumas C, Kricker A, et al,. Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Ann Surg Oncol 2012; 19: 1024-33.
35. Titus-Ernstoff L, Perry AE, Spencer SK, et al,. Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol 2006; 142: 433-8.
36. Duffy DL, Box NF, Chen W, et al,. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004; 13: 447-61.
37. Akey JM, Wang H, Xiong M, et al,. Interaction between the melanocortin-1 receptor and P genes contributes to inter-individual variation in skin pigmentation phenotypes in a Tibetan population. Hum Genet 2001; 108: 516-20.
38. Beaumont KA, Newton RA, Smit DJ, et al,. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 2005; 14: 2145-54.
39. Beaumont KA, Shekar SN, Newton RA, et al,. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 2007; 16: 2249-60.
40. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ,. Melanocortin 1 receptor variants: functional role and pigmentary associations. Photochem Photobiol 2011; 87: 978-87.
41. Busca R, Abbe P, Mantoux F, et al,. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J 2000; 19: 2900-10.
42. Wikberg JE, Muceniece R, Mandrika I, et al,. New aspects on the melanocortins and their receptors. Pharmacol Res 2000; 42: 393-420.
43. Motokawa T, Kato T, Hashimoto Y, Katagiri T,. Effect of Val92Met and Arg163Gln variants of the MC1R gene on freckles and solar lentigines in Japanese. Pigment Cell Res 2007; 20: 140-3.
44. Elfakir A, Ezzedine K, Latreille J, et al,. Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. J Invest Dermatol 2010; 130: 1107-15.
45. Scherer D, Bermejo JL, Rudnai P, et al,. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int J Cancer 2008; 122: 1787-93.
46. Kvaskoff M, Siskind V, Green AC,. Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia. Arch Dermatol 2012; 148: 164-70.
47. Wakamatsu K, Kavanagh R, Kadekaro AL, et al,. Diversity of pigmentation in cultured human melanocytes is due to differences in the type as well as quantity of melanin. Pigment Cell Res 2006; 19: 154-62.
48. Doyle JR, Fortin JP, Beinborn M, Kopin AS,. Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways. J Pharmacol Exp Ther 2012; 342: 318-26.
49. Thomas NE, Kanetsky PA, Begg CB, et al,. Melanoma molecular subtypes: unifying and paradoxical results. J Invest Dermatol 2010; 130: 12-14.